Assignee
ESSA PHARMA INC
CA·7 granted patents·12 pending applications·46 citations·filing 2019–2024
Top patents by PatentIndex Score
19 records- 0198US11358938B2Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2021·Granted Jun 14, 2022·8 cites·26 claims
- 0298US11242324B2Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2021·Granted Feb 8, 2022·9 cites·25 claims
- 0397US11518747B2Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2022·Granted Dec 6, 2022·6 cites·30 claims
- 0497US11059795B2Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2020·Granted Jul 13, 2021·12 cites·25 claims
- 0594US11814357B2Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2022·Granted Nov 14, 2023·1 cites·22 claims
- 0694US11485713B2Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2019·Granted Nov 1, 2022·10 cites·28 claims
- 0785US2024051926A1Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2023·Application pending·0 cites
- 0874US2021323931A1Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 0972US2024261282A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2024·Application pending·0 cites
- 1069US2022380325A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 1167US2020123117A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2019·Application pending·0 cites
- 1266US2022105093A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 1362US2023373934A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2023·Application pending·0 cites
- 1460US2024358701A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2022·Application pending·0 cites
- 1560US2024207264A1Pharmaceutical compositions comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2022·Application pending·0 cites
- 1658US12109179B2Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2020·Granted Oct 8, 2024·0 cites·23 claims
- 1758US2022380378A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2022·Application pending·0 cites
- 1852US2023078913A1Androgen receptor modulators and methods for use as proteolysis targeting chimera ligandsESSA PHARMA INC·Filed 2020·Application pending·0 cites
- 1951US2022202780A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →